1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Studies of white cell, platelet, and coagulation activation with plerixafor administration in patients with sickle cell disease
    Meeting Abstract

    Pham, P.; Barbu-Stevanovic, M.; Greenberg, J.; Guarneri, D.; Mitchell, B.; Minniti, C.; Narla, M.; Yazdanbakhsh, K.; Shore, T. B.; Boulad, F.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Enasidenib monotherapy is effective and well-tolerated in patients with previously untreated mutant-IDH2 (m IDH2) acute myeloid leukemia (AML)
    Meeting Abstract

    Pollyea, D. A.; Tallman, M. S.; De Botton, S.; DiNardo, C. D.; Kantarjian, H. M.; Collins, R. H.; Stein, A. S.; Xu, Q.; Tosolini, A.; Gupta, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Systematic combinatorial chimeric antigen receptor therapies to AML
    Meeting Abstract

    Perna, F.; Berman, S.; Soni, R. K.; Mansilla-Soto, J.; Eyquem, J.; Hamieh, M.; Hendrickson, R. C.; Brennan, C.; Sadelain, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Intestinal microbiota injury during allo-HSCT is generalizable across transplantation centers and is associated with increased mortality, broad-spectrum antibiotics, and decreased calorie intake
    Meeting Abstract

    Peled, J. U.; Gomes, A.; Buchan, M. L.; Stein-Thoeringer, C. K.; Slingerland, J. B.; Slingerland, A. E.; Weber, D.; Sung, A. D.; Maloy, M.; Peets, T.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Integrative epigenomics reveals novel chronic lymphocytic leukemia-specific chromatin states associated with epigenetic and transcriptional heterogeneity
    Meeting Abstract

    Pastore, A.; Gaiti, F.; Lu, S. X.; Abdel-Wahab, O.; Landau, D. A.
    Blood (2017)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Activation levels of b-catenin signaling in osteoblasts define a threshold for the development of myeloid neoplasia of variable severity
    Meeting Abstract

    Mosialou, I.; Cuesta-Dominiguez, A.; Bhagat, G.; Berman, E.; Raza, A.; Kousteni, S.
    Blood (2017)

    Fulltext@MSK | Save
  • The role of upfront hematopoietic stem cell transplantation (HSCT) in peripheral T-cell lymphoma (PTCL) patients in complete remission (CR) with a special focus on nodal PTCL: Report from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a prospective multicenter cohort study
    Meeting Abstract

    Park, S. I.; Horwitz, S. M.; Foss, F. M.; Pinter-Brown, L. C.; Carson, K. R.; Rosen, S. T.; Pro, B.; Hsi, E. D.; Federico, M.; Gisselbrecht, C.; more...
    Blood (2017)

    Fulltext@MSK | Save